bpc-157 third party tested supplier | Research Grade Peptide BPC-157 — Technical Lot Record

21 CFR 211.100(a) FDA cited 21 CFR 211.100(a) for failure to establish adequate written procedures for production and process control most frequently: 38 times across the 94 inspection-based warning letters reviewed

Treated tendons showed accelerated recovery with increased load to failure, meaning they could withstand greater force before breaking

[36] [37] In doses higher than intended for medicinal use, the hallucinogenic alteration of consciousness, as well as the delirium in particular, are tied to the compound's activity at the M 1 muscarinic receptor

20 mg total peptide per vial (10 mg + 10 mg) Purity: 99% (HPLC verified, each component) Container: sealed glass vial (lyophilized powder) Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for both component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information

Next Age Wellness makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment

[3] Alongside angiogenesis, BPC-157 modulates the nitric oxide system